SCHEMBL1002841

SCHEMBL1002841

CON(C)C(=O)c1cc(F)c(F)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.39
MTOR P42345 3/20 0.37
PIK3CA P42336 2/20 0.37
CLK1 P49759 1/20 0.36
DYRK1A Q13627 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.36
LPAR5 Q9H1C0 1/20 0.35
SLC6A3 Q01959 1/20 0.33
GPR119 Q8TDV5 3/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
ALOX5 P09917 1/20 0.33
NFKB1 P19838 1/20 0.33
STAT3 P40763 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
NFE2L2 Q16236 1/20 0.33
CPS1 P31327 1/20 0.33
CA1 P00915 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21374050 0.87 TRPM8 (0.36) MLYCDMTORPIK3CACLK1DYRK1A
SCHEMBL18075678 0.86 KMT2A (0.36) MLYCDMTORPIK3CACLK1DYRK1A
SCHEMBL2845005 0.86 LMNA (0.40) MLYCDMTORPIK3CACLK1DYRK1A
SCHEMBL31103821 0.86 KMT2A (0.36) MLYCDMTORPIK3CACLK1DYRK1A
SCHEMBL15918563 0.84 SLC6A3 (0.43) MLYCDMTORPIK3CACLK1DYRK1A
SCHEMBL18173746 0.81 KMT2A (0.39) MTORPIK3CAMEN1KMT2ATDP1
SCHEMBL4007735 0.80 CES2 (0.53) MLYCDMTORCLK1DYRK1ADYRK1B
SCHEMBL13265347 0.80 MLYCD (0.40) MLYCDMTORPIK3CACLK1DYRK1A
SCHEMBL6710893 0.80 CES2 (0.53) MLYCDMTORPIK3CATRPM8CYP11B1
SCHEMBL23003364 0.80 PTPN1 (0.36) MLYCDMTORPIK3CACLK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110015198-A1 DIARYLMETHYLAMIDE DERIVATIVE HAVING MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISM BANYU PHARMACEUTICAL CO., INC. 2011-01-20 US disclosed
EP-2272841-A1 DIARYLMETHYLAMIDE DERIVATIVE HAVING ANTAGONISTIC ACTIVITY ON MELANIN-CONCENTRATING HORMONE RECEPTOR Banyu Pharmaceutical Co., Ltd. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015198-A1 DIARYLMETHYLAMIDE DERIVATIVE HAVING MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISM MC1R, MCHR2, MCHR1 MLYCD 1589/4885MTOR 1691/4885PIK3CA 3837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.